Ford JM - Search Results

1

Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers.

Watkins J, Weekes D, Shah V, Gazinska P, Joshi S, Sidhu B, Gillett C, Pinder S, Vanoli F, Jasin M, Mayrhofer M, Isaksson A, Cheang MC, Mirza H, Frankum J, Lord CJ, Ashworth A, Vinayak S, Ford JM, Telli ML, Grigoriadis A, Tutt AN. Watkins J, et al. Among authors: ford jm. Cancer Discov. 2015 May;5(5):488-505. doi: 10.1158/2159-8290.CD-14-1092. Epub 2015 Mar 13. Cancer Discov. 2015. PMID: 25770156 Free PMC article.

2

Defective repair of oxidative dna damage in triple-negative breast cancer confers sensitivity to inhibition of poly(ADP-ribose) polymerase.

Alli E, Sharma VB, Sunderesakumar P, Ford JM. Alli E, et al. Among authors: ford jm. Cancer Res. 2009 Apr 15;69(8):3589-96. doi: 10.1158/0008-5472.CAN-08-4016. Epub 2009 Apr 7. Cancer Res. 2009. PMID: 19351835 Free PMC article.

3

Longer relative telomere length in blood from women with sporadic and familial breast cancer compared with healthy controls.

Gramatges MM, Telli ML, Balise R, Ford JM. Gramatges MM, et al. Among authors: ford jm. Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):605-13. doi: 10.1158/1055-9965.EPI-09-0896. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20142254

4

Comparison of intensity-modulated radiotherapy and 3-dimensional conformal radiotherapy as adjuvant therapy for gastric cancer.

Minn AY, Hsu A, La T, Kunz P, Fisher GA, Ford JM, Norton JA, Visser B, Goodman KA, Koong AC, Chang DT. Minn AY, et al. Among authors: ford jm. Cancer. 2010 Aug 15;116(16):3943-52. doi: 10.1002/cncr.25246. Cancer. 2010. PMID: 20564136 Free article.

5

Novel treatment approaches for triple-negative breast cancer.

Telli ML, Ford JM. Telli ML, et al. Among authors: ford jm. Clin Breast Cancer. 2010;10 Suppl 1:E16-22. doi: 10.3816/CBC.2010.s.003. Clin Breast Cancer. 2010. PMID: 20587403 Review.

6

Synergistic chemosensitivity of triple-negative breast cancer cell lines to poly(ADP-Ribose) polymerase inhibition, gemcitabine, and cisplatin.

Hastak K, Alli E, Ford JM. Hastak K, et al. Among authors: ford jm. Cancer Res. 2010 Oct 15;70(20):7970-80. doi: 10.1158/0008-5472.CAN-09-4521. Epub 2010 Aug 26. Cancer Res. 2010. PMID: 20798217 Free PMC article.

7

Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry.

Telli ML, Chang ET, Kurian AW, Keegan TH, McClure LA, Lichtensztajn D, Ford JM, Gomez SL. Telli ML, et al. Among authors: ford jm. Breast Cancer Res Treat. 2011 Jun;127(2):471-8. doi: 10.1007/s10549-010-1173-8. Epub 2010 Oct 19. Breast Cancer Res Treat. 2011. PMID: 20957431 Free PMC article.

8

PARP inhibitors in breast cancer.

Telli ML, Ford JM. Telli ML, et al. Among authors: ford jm. Clin Adv Hematol Oncol. 2010 Sep;8(9):629-35. Clin Adv Hematol Oncol. 2010. PMID: 21157412 Review.

9

Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines.

Powell AA, Talasaz AH, Zhang H, Coram MA, Reddy A, Deng G, Telli ML, Advani RH, Carlson RW, Mollick JA, Sheth S, Kurian AW, Ford JM, Stockdale FE, Quake SR, Pease RF, Mindrinos MN, Bhanot G, Dairkee SH, Davis RW, Jeffrey SS. Powell AA, et al. Among authors: ford jm. PLoS One. 2012;7(5):e33788. doi: 10.1371/journal.pone.0033788. Epub 2012 May 7. PLoS One. 2012. PMID: 22586443 Free PMC article.

10

PARP Inhibitors for the Treatment and Prevention of Breast Cancer.

Vinayak S, Ford JM. Vinayak S, et al. Among authors: ford jm. Curr Breast Cancer Rep. 2010 Dec;2(4):190-197. doi: 10.1007/s12609-010-0026-0. Curr Breast Cancer Rep. 2010. PMID: 22655123 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

638 results

Search Page

Filters